Search
Close this search box.
Browsing category

August 1, 2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to […]

Read More

Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials

Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon, marking a new era of […]

Read More

Police to restore law and order in Riverlea

Police Minister, General Bheki Cele, has assured the community of Riverlea that police are mobilising all their resources and specialised units to restore law and order in the area.On Monday, Cele led a high level delegation of senior police officers …

Read More

Socio-economic opportunities for women under spotlight

The acceleration of socio-economic programmes for women will take centre stage as the country commemorates Women’s Month.The Department of Women, Youth and Persons with Disabilities (DWYPD), in partnership with the Department of Sport, Arts and Cultur…

Read More

Search

Search

Advertisement

Recent Posts

Advertisement